UPR - UNIPHAR - Share Chat
Uniphar plc is an Ireland-headquartered, LSE-listed healthcare services company providing outsourced solutions to pharmaceutical and medical device manufacturers across Ireland, the UK, Europe, and the US. The group operates through three core divisions: Product Distribution, which includes wholesale pharmacy distribution; Commercial & Clinical, offering outsourced sales, marketing, and clinical trial services; and Supply Chain & Retail Services.
Uniphar’s strategy focuses on partnering with pharma companies to provide comprehensive services across the product lifecycle, from early-stage clinical access to market commercialisation and patient access programmes. Its higher-growth Commercial & Clinical division is expanding internationally, emphasising specialised, value-added services beyond traditional pharmaceutical wholesale. The company has demonstrated a consistent track record of growth, often supplemented by strategic acquisitions.
Chat about UNIPHAR
Uniphar's recent full-year results highlighted strong growth and an increased dividend. Are you impressed with their performance, particularly their M&A strategy? With the healthcare sector evolving, do you see continued upside for UPR shares, or are current valuations looking stretched? Interested to hear diverse views.